TransMedics: A Stagnant Monopoly Facing Regulatory Pressure (NASDAQ:TMDX)

Company Overview - TransMedics, Inc. is the manufacturer and supplier of the patented Organ Care System (OCS) which utilizes warm-perfusion technologies for transporting viable organs over long distances to recipients [1] Investment Approach - The investment approach taken by the company involves a holistic view that incorporates both top-down and bottom-up valuation techniques, emphasizing the importance of detailed company aspects such as capital structure and debt covenants in equity valuation [1]